News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
81 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18934)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1410)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (80)
7 (151)
8 (89)
9 (81)
10 (30)
13 (140)
14 (106)
15 (102)
16 (135)
17 (49)
19 (25)
20 (84)
21 (88)
22 (18)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
Artificial intelligence
Biopharma R&D needs ‘structural redesign’ to maximize AI impact: report
Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.
July 9, 2026
·
2 min read
·
Nick Paul Taylor
Rare diseases
Saol boards FDA’s resubmission boat, armed with new survival data
Saol Therapeutics is the latest biotech to resubmit for approval of a drug rejected under former FDA Commissioner Marty Makary, following REGENXBIO and Replimune.
July 9, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
July 9, 2026
·
3 min read
Press Releases
Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine
July 9, 2026
·
3 min read
Press Releases
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
July 9, 2026
·
9 min read
Press Releases
Roche receives CE Mark for blood test to identify tuberculosis infection
July 9, 2026
·
6 min read
Press Releases
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
July 9, 2026
·
10 min read
Press Releases
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
July 9, 2026
·
6 min read
Press Releases
Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy
July 9, 2026
·
7 min read
Press Releases
Cytosurge’s CellEDIT Conquers “Impossible” Genome Engineering Challenges
July 9, 2026
·
3 min read
1 of 9
Next
